AI assistant
Sending…
REVVITY, INC. — Director's Dealing 2004
Apr 29, 2004
30616_dirs_2004-04-29_62ce1960-1a6e-46f8-a9e3-df5c760c8427.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PERKINELMER INC (PKI)
CIK: 0000031791
Period of Report: 2004-04-27
Reporting Person: MULLEN JAMES C (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2004-04-27 | Common Stock | A | 3014 | $19.91 | Acquired | 4020 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2004-04-27 | NQ Stock Option (Right to Buy) | $19.91 | A | 5854 | Acquired | 2014-04-27 | Common Stock (5854) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| NQ Stock Option (right to buy) | $19.84 | 2014-01-27 | Common Stock (10000) | 10000 | Direct |
Footnotes
F1: Annual Directors Grant of Restricted Stock -- Fully vested
F2: 2004 Director's Stock Option. This option will vest equally over a four (4) year period and will have a ten (10) year exercise term.
F3: This transaction was previously reported on 1/29/04 but has been included to reflect a correction. The exercise price for the shares is $19.84 and not $19.88.
F4: This option will vest equally over a four (4) year period and will have a ten (10) year exercise term.
More from REVVITY, INC.
Regulatory Filings
2026
Jun 1
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 5
Declaration of Voting Results & Voting Rights Announcements
2026
May 1
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Mar 16
Proxy Solicitation & Information Statement
2026
Mar 16
Proxy Solicitation & Information Statement
2026
Mar 16
Regulatory Filings
2026
Mar 6